Raksha Trivalent

Each dose contains: bivalent FMD inactivated antigens of O and A strains adsorbed on to aluminium hydroxide gel. Saponin added as adjuvant chlorofom B.P as preservative 0.015mL, phosphate buffer diluent q.s

Raksha-HS+BQ vaccine contains formalin inactivated cultures of Pasteurella multocida and Clostridium chauvoei adjuvanted with aluminium hydroxide gel

Each dose contains: bivalent FMD inactivated antigens of O and Asia-1 strains adsorbed on to aluminium hydroxide gel. Mineral oil added as adjuvant thiomersal B.P as preservative ≤ 0.02% w/v, phosphate buffer diluent q.s

Each dose contains: monovalent FMD inactivated antigens of Asia-1 strain adsorbed on to aluminium hydroxide gel. Mineral oil added as adjuvant thiomersal B.P as preservative ≤ 0.02% w/v, phosphate buffer diluent q.s

Each dose contains: trivalent FMD inactivated antigens of O, A and Asia-1 strains adsorbed on to aluminium hydroxide gel. Mineral oil added as adjuvant thiomersal B.P as preservative ≤ 0.02% w/v, phosphate buffer diluent q.s

sheep pox + PPR vaccine (Peste des Petits ruminants vaccine) composition: Each 1mL contains: sheep pox virus titer ≥ 10TCID50 [propagated on Vero cells] PPr virus titer ≥ 102.5 TCID50 [propagated on Vero cells], sucrose and lactalbumin hydrolysate addes as stabilizers. sterile diluent: Each 1mL contains...

HS vaccine (multocida & haemolytica) Each dose contains pasteurella multocida I.P (vet.) and M. haemolytica B.P (Vet.) (formerly known as pasteurella haemolytica), inactivated antigens adsorbed on aluminium hydroxide gel, formaldehyde as preservative

Raksha-ET vaccine contains inactivated culture of anaerobically grown Clostridium Welchii Type – D organisms. The prototoxin is converted into toxin by trypsinization. The toxin is then rendered non-toxic by formalisation. This is then adjuvanted with aluminium hydroxide gel.

Each dose contains: Monovalent FMD inactivated antigen of O strain adsorbed on to aluminium hydroxide gel. Saponin added as adjuvant chlorofom B.P as preservative 0.015mL, phosphate buffer diluent q.s

Each dose contains: monovalent FMD inactivated antigens of Asia-1 strain adsorbed on to aluminium hydroxide gel. Mineral oil added as adjuvant thiomersal B.P as preservative ≤ 0.02% w/v, phosphate buffer diluent q.s

Raksha-Ovac monovalent contains: monovalent FMD inactivated antigens of O strain adsorbed on to aluminium hydroxide gel. Mineral oil added as adjuvant thiomersal B.P as preservative ≤ 0.02% w/v, phosphate buffer diluent q.s

Peste des Petits ruminants vaccine, live Each dose contains: PPR virus titer ≥ 102.5 TCID 50 [propagated on vero cells], maltose, gelatin and lactalbumin hydrolysate added as stabilizer Sterile diluent: Each 1mL contains: disodium hydrogen ortho phosphate anhydrous B.P, potassium dihydrogen phosphate B.P,...

Indian Immunologicals Limited, in collaboaration with Griffith University, Australia is going to commence research for developing a vaccine for Corona virus, the pandemic which has infected more than two million and killed about 250,00 people across the world. 

Even WHO has considered the same in its latest draft landscape of COVID 19 vaccine candidates dated 30th April, 2020.